DALRD3
Basic information
Region (hg38): 3:49015488-49022293
Links
Phenotypes
GenCC
Source:
- undetermined early-onset epileptic encephalopathy (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 86 (Limited), mode of inheritance: AR
- developmental and epileptic encephalopathy, 86 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Epileptic encephalopathy, early infantile, 86 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 32427860 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DALRD3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 29 | 31 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 33 | 5 | 2 |
Variants in DALRD3
This is a list of pathogenic ClinVar variants found in the DALRD3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-49015608-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
3-49015611-G-C | not specified | Uncertain significance (May 24, 2024) | ||
3-49015634-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
3-49015671-G-A | not specified | Uncertain significance (Jun 22, 2021) | ||
3-49015700-C-T | not specified | Uncertain significance (May 14, 2024) | ||
3-49015786-A-G | Benign (Feb 20, 2022) | |||
3-49015850-A-C | not specified | Uncertain significance (May 18, 2022) | ||
3-49016004-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
3-49016067-A-G | not specified | Uncertain significance (May 05, 2023) | ||
3-49016070-A-C | not specified | Uncertain significance (Mar 06, 2023) | ||
3-49016160-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
3-49016186-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
3-49016210-T-A | not specified | Uncertain significance (Aug 26, 2024) | ||
3-49016236-G-T | Developmental and epileptic encephalopathy, 86 | Conflicting classifications of pathogenicity (Mar 29, 2024) | ||
3-49016261-C-T | not specified | Uncertain significance (Sep 26, 2024) | ||
3-49016262-G-A | Developmental and epileptic encephalopathy, 86 | Uncertain significance (Apr 25, 2021) | ||
3-49016306-G-A | not specified | Uncertain significance (Feb 26, 2024) | ||
3-49016485-C-T | Likely benign (Apr 01, 2024) | |||
3-49016632-T-C | not specified | Uncertain significance (Nov 24, 2024) | ||
3-49016641-G-A | not specified | Uncertain significance (Nov 03, 2022) | ||
3-49016642-C-A | not specified | Uncertain significance (Jul 26, 2024) | ||
3-49016658-C-A | not specified | Uncertain significance (Nov 18, 2022) | ||
3-49016843-T-A | not specified | Uncertain significance (Dec 17, 2021) | ||
3-49017259-T-C | Benign (Apr 19, 2019) | |||
3-49017268-A-T | not specified | Uncertain significance (Apr 04, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DALRD3 | protein_coding | protein_coding | ENST00000341949 | 12 | 6806 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.69e-10 | 0.378 | 125619 | 0 | 129 | 125748 | 0.000513 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.273 | 269 | 282 | 0.954 | 0.0000142 | 3414 |
Missense in Polyphen | 71 | 78.935 | 0.89948 | 1002 | ||
Synonymous | 0.0488 | 116 | 117 | 0.994 | 0.00000576 | 1181 |
Loss of Function | 1.03 | 18 | 23.4 | 0.771 | 0.00000107 | 264 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00107 | 0.00107 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000979 | 0.000979 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000611 | 0.000607 |
Middle Eastern | 0.000979 | 0.000979 |
South Asian | 0.000298 | 0.000294 |
Other | 0.000509 | 0.000489 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.0875
Intolerance Scores
- loftool
- 0.701
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.2
Haploinsufficiency Scores
- pHI
- 0.776
- hipred
- N
- hipred_score
- 0.178
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.528
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dalrd3
- Phenotype
Gene ontology
- Biological process
- arginyl-tRNA aminoacylation
- Cellular component
- Molecular function
- arginine-tRNA ligase activity;protein binding;ATP binding